With the conclusion of its latest funding cycle, the Mesothelioma Applied Research Foundation has reached the milestone of $10 million in grant funding awarded to the most promising mesothelioma research projects across the globe. The Foundation is the only non-governmental institution to fund mesothelioma research through a transparent, merit-based process modeled after the National Institutes […]
Mesothelioma researcher and Meso Foundation grant recipient Prasad S. Adusumilli, MD, FACS, FCCP, of the Memorial Sloan Kettering Cancer Center (MSKCC) was an author on the review article CAR T-cell therapy for lung cancer and malignant pleural mesothelioma recently published in Translational Research: The Journal of Laboratory and Clinical Medicine.
Dr. Adusumilli is a thoracic surgeon-scientist […]
The American Society of Clinical Oncology (ASCO) held its Annual Meeting on June 2-6, 2017 in Chicago. The Meso Foundation’s CEO, Melinda Kotzian, had the opportunity to attend the conference and hear the latest news reported in mesothelioma research.
Hedy Lee Kindler, MD, of the University of Chicago, presented a poster on the results from a […]
On June 5, Anna Nowak, MD, PhD, of the University of Western Australia and member of the Meso Foundation’s Science Advisory Board, presented phase II results from LUME-Meso, a mesothelioma clinical trial sponsored by Boehringer Ingelheim, at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
LUME-Meso is a randomized, double-blind, placebo-controlled trial evaluating […]
With the passage of the Omnibus budget bill last week, mesothelioma research will now be eligible for $60 million, an increase of $10 million over the amount previously available.
This particular funding is available through the Department of Defense’s Peer-Reviewed Cancer Research Program (PRCRP), a pot of funding available annually to researchers studying any one of […]